|
| |
Abstract |
|---|
|
|
|---|
Clinically, nitric oxide (NO·) is widely used as a pulmonary vaso- and bronchodilator agent. However, the
precise molecular mechanisms by which NO· induces smooth muscle relaxation are not well established. It
has been suggested that NO· relaxes airway smooth muscle (ASM) via a 3',5'-cyclic guanosine monophosphate (cGMP)-dependent pathway, and our previous work has shown that Ca2+-activated K+ (KCa)
channels are susceptible to cGMP-dependent protein kinase (PKG)-dependent phosphorylation (A. Alioua, J. P. Huggins, and E. Rousseau. Am. J. Physiol. 1995;268:L1057-L1063). To assess whether KCa
channels are also directly activated by NO· or one of its derivatives such as peroxynitrite, the activity of
these channels was measured upon fusion of sarcolemmal vesicles derived from bovine tracheal smooth
muscle cells into planar lipid bilayers (PLB). It was found that in the absence of adenosine triphosphate (ATP), cGMP, and cGMP-dependent protein kinase, NO· donors such as 1-propanamine-3-(2-hydroxy-2-nitroso-1-propylhydrazine) (PAPA NONOate) or 3-morpholinosydnonimine hydrochloride (SIN-1) in the presence of superoxide dismutase (SOD), added on either side of the bilayer, caused a concentration-
dependent increase in the open probability (Po) of KCa channels without altering their unitary conductance.
Release of NO·, which was measured by chemiluminescence analysis in parallel experiments, affected the
gating behavior of KCa channels in the presence of SOD and ethyleneglycol-bis-(
-aminoethyl ether)-
N,N'-tetraacetic acid (EGTA) by reducing the mean closed times and increasing the number and duration
of short open events. PAPA NONOate, a true NO· donor, had similar effects in the presence of ethylenediaminetetraacetic acid (EDTA), a heavy-metal chelator, and K-urate, a peroxynitrite scavenger. Addition of
either 5 mM dithiothreitol (DTT) or 5 mM reduced glutathione (GSH), as well as 5 mM N-ethylmaleimide
(NEM)
an alkylating agent
to the trans (intracellular) side of an experimental chamber slightly increased channel Po but prevented further channel activation by NO· donors. However, neither DTT nor
GSH was able to reverse the effect of NO·. In contrast to SIN-1, DTT had no effect when added to the cis
(extracellular) side of the chamber. This suggests that the effect of NO· is most likely due to a chemical
modification (nitrothiosylation) of intracellular sulfhydryl group(s). Neither PAPA NONOate (NO·), nor
SIN-1 had any effect on sarcolemmal Cl
channels reconstituted from the same membrane preparations.
Pharmacomechanical measurements made on epithelium-denuded rat bronchus showed that 100 nM
charybdotoxin decreased the sensitivity of bronchial smooth muscle to SIN-1-induced relaxations. Altogether, our data suggest that NO-induced bronchorelaxation occurs partly via a direct activation of KCa
channels, possibly through a covalent interaction with the cytoplasmic side of their
subunit.
| |
Introduction |
|---|
|
|
|---|
Ca2+-activated K+ (KCa) channels are located on the surface of a variety of cells, including airway smooth muscle
(ASM) cells (1, 2), where they are involved in the regulation of membrane polarization and, in turn, of muscle tone
(3). The activity of this type of channel is under the control
of many substances, including some used frequently for
clinical treatments (4). One of these substances, nitric oxide (NO·), was initially identified as the endothelium-derived
relaxing factor (EDRF) (5, 6). In the airways, NO· is released principally by inhibitory nonadrenergic, noncholinergic (NANC)i neurons or by epithelial cells to modulate the tone of adjacent smooth muscle cells (7). The
mechanisms by which NO· induces its relaxing effect have
been extensively studied in the vascular system (11, 12),
but much less investigated in ASM, despite their clinical
relevance (13). NO· is thought to act through activation of
the soluble guanylate cyclase enzyme that catalyzes a transient increase in the cytoplasmic level of guanosine 3',5'-cyclic monophosphate (cGMP). This increase in cGMP
activates a cGMP-dependent protein kinase (PKG) that
phosphorylates different key proteins implicated in smooth
muscle relaxation (14). Previous pharmacological studies
performed on ASM have shown that specific inhibitors of
KCa channels antagonize the relaxation induced by either
endogenous (8) or exogenous NO· (11, 15), suggesting that
this type of channel is one of the effectors by which NO· induces its relaxing effect. Moreover, it has been reported
that KCa channels in airways account for almost 50% of
NO-mediated relaxation (8, 11), compared with only 20-
40% in vascular smooth muscle (VSM). These observations indicate the existence of differences in the molecular
mechanisms that lead to KCa-channel activation in VSM
and ASM. Indeed, previous patch-clamp experiments revealed two modes of KCa-channel activation by NO· in VSM:
a cGMP-dependent mechanism, involving activation of guanylate cyclase and a PKG-dependent phosphorylation step (16), and a cGMP-independent mechanism (19). Despite frequent reports that the activation of KCa channels
mediates relaxation elicited by NO· in ASM (7, 20, 21),
it has never been shown whether or not the effect of NO
was due to a cGMP-independent mechanism. However, in
a recent study, we demonstrated that native and purified
KCa channels, derived from bovine tracheal smooth muscle
cells and reconstituted into planar lipid bilayers (PLB), were
activated by a PKG-dependent phosphorylation of the KCa
channel in the presence of cGMP, Mg-ATP, and PKG (22).
Biochemical assays using [
-32P]ATP also revealed that
PKG phosphorylates a protein identified as being part of
the
-subunit of the KCa channel (23, 24). Thus, in ASM, one
mode of KCa-channel activation would be cGMP-dependent.
The mechanisms by which NO·, released from nerve terminals via NANC stimulation and/or airway epithelial cells, triggers ASM relaxation are still not fully understood. On the basis of results of previous studies, at least three intracellular pathways have been proposed to explain how NO· can decrease smooth muscle tone. The first two pathways would depend on an increase in the level of intracellular cGMP, owing to activation of the soluble guanylate cyclase by NO· (11, 15). In ASM, these pathways result in the phosphorylation of either regulatory proteins of the contractile elements or surface-membrane channels. Bolotina and colleagues (19) recently demonstrated that in VSM, NO·-induced relaxation might be independent of an increase in the level of cGMP. Their patch-clamp measurements supported a direct activation of KCa channels by NO·. Our working hypothesis assumed that this third pathway may also exist in ASM, but it had not yet been investigated in in vitro experiments. Therefore, the aim of our investigation was to test whether NO· can activate KCa channels by directly regulating single KCa channels into PLB. Direct measurements of KCa-channel activities were made with 3-morpholinosydnonimine hydrochloride (SIN-1) as an NO· donor in reconstitution experiments under free-[Ca2+] and voltage-clamp conditions. Pharmacomechanical measurements were made in parallel to evaluate the sensitivity of precontracted smooth muscle strips to NO-induced relaxation. We demonstrated that the activation of KCa channels mediates part of NO-induced ASM relaxation. Moreover, this relaxation appeared to result in part from a direct cGMP-independent activation of KCa channels by NO·, involving a nitrothiosylation reaction that could change the gating of the KCa channel without affecting its Ca2+ sensitivity.
| |
Materials and Methods |
|---|
|
|
|---|
NO· donor Preparations
NO· is highly unstable in solution. Therefore, we used the
relatively more stable compounds 1-propanamine-3-(2-hydroxy-2-nitroso-1-propylhydrazine (PAPA NONOate) or
SIN-1 as sources of NO·. PAPA NONOate was prepared as a 9-mM basic stock solution in 10 mM NaOH, pH 11, and stored at
20°C. Before each experiment, a sample of
this stock solution was thawed and diluted 3-fold in the
appropriate KCl buffer, pH 8, saturated with argon gas.
An aliquot of this 3-mM PAPA NONOate solution was
then added to the 3-ml experimental chamber to achieve the final concentrations. SIN-1 degrades to SIN-1A and
then to SIN-1C after releasing O2·, NO·, and a proton (25).
When O2· is liberated as a free radical, superoxide dismutase (SOD) has to be present to eliminate O2· in order to
prevent or at least to limit the production of peroxynitrite
(ONOO
) that would result from the oxidation of NO· in
the presence of trace quantities of metals. Thus, all experiments were performed in the presence of ethyleneglycol-
bis-(
-aminoethyl ether)-N,N'-tetraacetic acid (EGTA)
and/or ethylenediaminetetraacetic acid (EDTA) to chelate these trace contaminants.
SIN-1 was diluted in the following solution (in mM): 50 KCl, 20 potassium-4-(2-hydroxyethyl)-1-piperazine-N'-2-ethanesulfonate (K-Hepes), and 0.002 free Ca2+ (109 µM CaCl2 + 110 µM K-EGTA), pH 7.4, containing 50 U/ml SOD (Sigma Chemical Co., St. Louis, MO) to prevent NO· breakdown (26) and peroxynitrite formation (27, 28). The solution was prepared 15 min before being tested experimentally, and was not used thereafter for longer than 1 h after the time of its preparation. It was also continually kept protected from ultraviolet (UV) irradiation by natural light. During all experiments, the pH, temperature, and susceptibility of solutions to O2 were controlled in order to keep quantitatively constant the amount of NO· released from SIN-1 (25). The capacity of SIN-1 to release NO· was verified biologically by its ability to induce a sustained relaxation of bronchial smooth muscle for at least 1 h. Furthermore, NO· production in our KCl buffer system was ascertained by direct chemiluminescence measurements made with a Sievers 270B NO· analyzer (Sievers Institute, Boulder, CO) and standard protocols previously described (29).
Bronchial Smooth Muscle Strips Preparation and Isotension Measurements
Male rats (Sprague-Dawley) weighing 225-250 g were killed by exsanguination after intraperitoneal injection of sodium pentobarbital (50 mg/kg body weight). The lungs and airways were quickly removed and placed in Krebs solution. The main bronchial tissues were dissected and cut helically as previously described (30), and the epithelial cells (EC) were removed to eliminate any possible contribution of endogenous NO· or epithelial-derived hyperpolarizing factor (EDHF), both of which have been shown to modulate smooth muscle tone (31, 32). The absence of EC was confirmed histologically. Each bronchial strip was mounted in a 5-ml jacketed organ bath containing Krebs-bicarbonate solution (KBS) composed of (in mM): 118.1 NaCl, 4.7 KCl, 1.2 MgSO4 · 7 H2O, 1.2 KH2PO4, 25 NaHCO3, 2.5 CaCl2, and 11 glucose, pH 7.4, gassed with 95%O2-5%CO2 at 37°C. Contractions and relaxations were measured isometrically with a Grass Polygraph (Model 7D; Grass Instruments Co., Quincy, MA) as changes in tension. The tissues were subjected to an initial loading tension of 1 g and allowed to equilibrate for 60 min (with changes of bath medium every 15 min) before the experiments were begun (33). Following incubation in the presence of 10 µM methylene blue (MB), the bronchial strips were precontracted with 0.2 µM carbamylcholine chloride (Sigma) after which single doses or cumulative doses of SIN-1 (Biomol Research Laboratories, Inc., Plymouth, PA) were applied. The relaxation response to a given dose of SIN-1 was expressed as a percentage of the maximum tension induced by carbachol.
Preparation of Tracheal Smooth Muscle Microsomal Fractions and Channel Recording
The crude microsomal fraction was prepared as described previously (33). The reconstitution system consists of two experimental chambers, denoted cis and trans, separated by a septum with a 250-µm-diameter hole. The cis chamber was connected to an operational amplifier (Model 8900; Dagan, Minneapolis, MN) and the trans chamber was connected to virtual ground by means of two low-resistance MERE 2 electrodes (World Precision Instruments, Inc., Sarasota, FL). The hole was pretreated with a mixture of phospholipids at a concentration of 25 mg/ml chloroform in a ratio of 3:2:1 (wt/wt) of phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL). PLB were formed from the application of the same phospholipid solution dissolved in decane. The experimental chambers contained the following solutions (in mM): 250 KCl cis/50 KCl trans, plus 20 K-Hepes and 0.01 free Ca2+ (109 µM CaCl2 + 100 µM K-EGTA), pH 7.4. Microsomal fractions enriched in sarcolemmal vesicles (10-60 µg of proteins) were fused into the PLB from the cis chamber in such a way that the cis chamber corresponded to the extracellular side and the trans chamber to the cytoplasmic side of the channel. Currents generated by the reconstituted KCa channels were filtered (cutoff frequency, 10 kHz) and recorded on videotape (DAS/VCR 900; Toshiba, Minneapolis, MN). Currents were displayed on-line on a chart recorder (DASH II Model MT; Astro-Med, Inc., West Warwick, RI) for trace illustrations, or were played back, filtered at 1 kHz, and digitalized at 2 kHz for storage in 2-min files on a hard disk. All reconstitution studies were performed at room temperature (22 ± 2°C) (mean ± SEM). KCa-channel activities were analyzed in terms of current amplitudes and open-channel probability (Po). Multiple-channel activities were routinely recorded (~ 70%). Po values were determined as described previously (22, 33) and were expressed as NPo, where N is the total number of channels recorded experimentally. The number of channels functionally active within the bilayer was determined at the beginning of each recording, in the presence of 10 µM free Ca2+ (trans) cytoplasmic and at a holding potential (+30 mV) under which the Po of KCa is maximal (4, 22). KCa-channel activation was determined as NPo in the presence of NO· donor divided by NPo under control (low [Ca2+]) conditions over the same period of time.
Statistical Analysis
Results are means ± SEM (n = 3-7). Mean values were compared through paired Student's t tests, using the Sigma Plot program (Jandel Scientific Software, San Rafael, CA).
| |
Results |
|---|
|
|
|---|
Measurements of NO· Release from SIN-1 Degradation
To verify that SIN-1 was able to release NO· under our experimental conditions, we made specific measurements
with an NO· analyzer (29). Figures 1a through 1c illustrate
the detection signal for NO· production in the absence and
presence of SOD. The stock solution was able to release
NO· for up to 2 h after solubilization of SIN-1 and storage
at
20°C (data not shown). However, the solution was always used within an hour of solubilization of SIN-1, as indicated in the first paragraph of the MATERIALS AND METHODS section. Hence, 90% of NO· was released within 10 min of addition of SIN-1 to the experimental solution at
22°C (Figures 1a through 1c). This time (10 min) correlates fairly well with the activation periods observed for
the KCa channels in the PLB, which typically occurred
within 2 to 7 min (see the following discussion). Note that
in the presence of SOD, NO· was released over a longer
period of time (Figure 1b).
|
Recording of Ca2+-sensitive Large Conducting K+ Channels
Single-channel activity was recorded in an asymmetric (50 mM trans/250 mM cis) KCl buffer system at 0 mV as a
function of the free [Ca2+] in the cis chamber. Figure 2a
shows that upon cumulative addition of EGTA in the trans
chamber, the free [Ca2+] was decreased sequentially from
10 µM to 2 µM, 0.3 µM, and 0.1 µM. The single-channel
current amplitude was unaffected by the reduction of free
[Ca2+] in the trans chamber; rather, this resulted in a stepwise decrease of the open probability (Po). The Ca2+ sensitivity of the large conducting K+ channels (245 pS) is
quantified in Figure 2b. At submicromolar free [Ca2+], the
channel activity was very low. However, a sigmoidal relationship was obtained by plotting steady-state Po values
against increasing free [Ca2+] in the trans chamber (n = 4).
The channel was maximally activated (Po
0.7 at 0 mV)
at a free [Ca2+] higher than 2 µM, with half-maximal activation observed at a free [Ca2+] of 0.40 µM. This type of
conducting and gating behavior is similar to the behavior
described for large conducting KCa channels from various
tissues, including smooth muscle cells, upon patch-clamp recording in the cell-attached or inside-out configurations
(34). It also corresponds to the functional fingerprint of
the reconstituted KCa channel found in our previous studies (22, 31).
|
NO·, But Not the End-Products of SIN-1, Relaxes Bronchial Smooth Muscle and Activates Reconstituted KCa Channels
In solution, SIN-1 generates NO· and other secondary products (25, 27). To demonstrate that NO· but no other degradation products of SIN-1 were involved in bronchial smooth-muscle (BSM) relaxation, as well as in activating reconstituted KCa channels, a set of control experiments was performed as shown in Figure 3. SIN-1 solutions, prepared and kept for up to a week at 22°C in order for the secondary products to accumulate, very slightly relaxed precontracted BSM strips (< 5%), even at high concentrations (> 200 µM). In contrast, 50 µM of freshly prepared SIN-1 (see the MATERIALS AND METHODS section) induced 55% relaxation (Figure 3a), indicating that NO· was the sole active substance responsible for BSM relaxation with the SIN-1 solution.
|
Figure 3b illustrates a typical experiment in which the KCa currents were recorded in 50 mM KCl trans/250 mM KCl cis and a free [Ca2+] of 10 µM. At a holding potential of 0 mV, the channels were highly active (Figure 3b, first trace). Their activity was greatly diminished after reducing the free [Ca2+] below 0.5 µM on the cytoplasmic side of the channel (trans chamber; Figure 3b, second trace). Variations in [Ca2+] were achieved by addition of precalibrated amounts of EGTA, calculated according to Fabiato (35). Note that these changes in trans (cytosolic face) free Ca2+ concentrations also allow one to ascertain the orientation (sidedness) of the channels within the PLB. Neither addition of the vehicle (Figure 3b, third trace) nor that of 50 µM old SIN-1 solution (Figure 3b, fourth trace) modified the activity of the channels. When 50 µM of freshly prepared SIN-1 was added, all the channels were simultaneously activated, without any change in their current amplitudes or unitary conductance (Figure 3b, lower trace), indicating that NO· directly activates the KCa channel by means of an interaction with the channel protein.
Dose-dependent Activation of Reconstituted KCa Channels by NO· through a cGMP-independent Mechanism
To ascertain further the specific and direct effect of NO· on
the activity of reconstituted ASM KCa channels within the
PLB, multiple-channel activities were recorded. These
channels exhibited a high degree of activity in the presence of 10 µM Ca2+ at 0 mV, as shown in Figure 3b. To visualize better their activation by SIN-1, the activity of KCa
channels was decreased by reducing [Ca2+]trans to 0.3 µM
(Figure 4a, first trace). Upon addition of cumulative doses
of SIN-1, the steady-state activities of the channels increased in a dose-dependent manner (Figure 4a, second
and following traces). Quantitative analysis of the activation of KCa channels by NO· is reported in Figure 4b. The
dose of SIN-1 that caused half of the maximal effect was
estimated to be 30 µM. The maximal stimulation of KCa
channels was obtained with 100 µM SIN-1, which corresponded to an ~ 5-fold activation. It is noteworthy that NO-induced KCa-channel activation never reached the initial
activity recorded in the presence of 10 µM Ca2+, suggesting that NO· most likely activated KCa channels by a direct
interaction. However, since NO· and Ca2+ have different
physicochemical properties, the presence of NO-specific interaction sites
different from the binding sites for Ca2+-induced activation
within the KCa-channel proteins can
be postulated.
|
Time Analysis of NO· Activation
To test the way in which NO· modifies KCa-channel gating
and thus increases channel Po, open- and closed-time analyses were performed on single-channel recordings. Figure
5a displays the results obtained from a typical experiment.
Channel activities were sequentially recorded in the presence of high (10 µM) and low (0.3 µM) trans [Ca2+], following the addition of 100 µM SIN-1 (NO·), and upon addition of 5 mM dithiothreitol (DTT). The channel's open
probability was reduced by lowering the trans [Ca2+] whereas
SIN-1 (NO·) and DTT slightly reversed this effect. To quantify the effects of [Ca2+], NO·, and DTT on the gating behavior of the KCa channel, time analyses of the open and
closed events were performed by computation of cumulative-time histograms and corresponding curve fitting of
the various distributions, as previously done (22, 33). Data
obtained from three separate experiments were compiled
and are shown in Figure 5b. The values of the mean open
times (Figure 5b, upper panel) show that SIN-1 (NO·)
slightly increased the short time constant (
op1) when compared with the average values measured in a high or low
trans [Ca2+]. In contrast, the unsuspected activating effect
of DTT, which will be further discussed subsequently, resulted in a lengthening of the mean "short" (
op1) and
"long" (
op2) open events.
|
The main effect of SIN-1 (NO·) consisted of a decrease
in the mean duration of closed events compared with the
values determined with a low trans [Ca2+] (Figure 5b,
Cl1
and
Cl2, lower panel). Thus, SIN-1 appeared to affect the
gating behavior of KCa channels by reducing the mean duration of shut intervals and increasing the number of short open events, which is consistent with the observations
made from multiple-channel recordings (Figures 3b and
4a). Note that the slight overall increase in Po measured
following the addition of DTT was the result of an increase in mean open times. DTT had no further effect on
mean closed times when added after SIN-1.
Effect of Reducing and Alkylating Agents
Because it has been proposed and shown that NO· might react with sulfhydryl groups (9), we tested the effect of NO· before and/or after addition of various reducing and alkylating agents. Table 1, rows a and b, summarizes the data obtained in various experiments in which either DTT (5 mM) or reduced glutathione (5 mM GSH) was initially used to reverse the activation induced by 100 µM SIN-1 (NO·) at a low free [Ca2+] in the trans chamber (intracellular side of the channels). Note that 5 mM DTT or GSH did not reverse the positive effect of NO· on the open probability of the channel. In fact, the addition of the reducing agents resulted in slight activation, which was quite the opposite of the suspected effect. Table 1, row c, shows that 5 mM N-ethylmaleimide (NEM) activated the channels in the presence of a low free [Ca2+] in the trans chamber, but more importantly prevented further activation by NO· following the addition of SIN-1. It is noteworthy that in all these experiments, subsequent addition to the trans chamber of an amount of Ca2+ that was precalibrated to yield 10 µM Ca (Table 1, rows a through c, right column) reactivated the KCa channels with Po values close to values determined under control conditions (Table 1, rows a through c, left column), suggesting that the site of Ca2+ activation of the KCa channels is independent of the site of NO· activation. Similar results were obtained when DTT was added in the trans chamber prior to NO· challenge, as shown in Figures 6a and 6b on a multiple-channel recording. The channels were fully activated by 10 µM Ca2+ (Figure 6a, upper trace) until the Po was reduced by lowering the trans free [Ca2+] (second trace). Adding 5 mM DTT trans partially activated KCa channels at a low free [Ca2+]trans, but prevented further activation by NO· following the addition of 100 µM SIN-1 in the same chamber. DTT activation of KCa channels was observed in 11 of 13 trials. Furthermore, the DTT effect was dose-dependent between 0.3 and 10 mM (data not shown), suggesting that more than one cysteine (SH) or disulfhydryl (S-S) group are involved in channel-protein activation. However, as shown in Figure 6b, DTT effects on KCa channels in the presence of SIN-1 did not prevent their reactivation by Ca2+ (Figure 6b, far-right bar histogram), suggesting the existence of two independent activation processes, in addition to the voltage-dependent activation, which was preserved (data not shown).
|
|
Sidedness of NO· Effect
Our initial results showed that the addition of SIN-1 on either side of the PLB activated KCa channels, an expected observation considering that NO· molecules readily diffused across the lipid bilayer. It was of interest to determine the location of the action of these NO· molecules, and the following experiments were aimed at demonstrating the sidedness of the NO· activation.
Complementary experiments were performed wherein the reducing agent was tested on the cis side of the experimental chamber prior to addition of SIN-1 on the same side (Figure 7). First, the orientation of the GKCa channel in the PLB was ascertained by addition of EGTA, which resulted in a decrease in the free [Ca2+] in the trans chamber or cytoplasmic side of the proteins (Figure 7a, upper traces). Adding 5 mM DTT in the cis chamber failed to produce any effect on the gating or conducting behavior of KCa channels, which contrasted with the results shown in Figures 6a and 6b, where DTT had been added to the opposite chamber. However, addition of 100 µM SIN-1 in the cis chamber partially reactivated the channels present in the bilayer. At a constant low free [Ca2+], this reactivation might be due to NO· molecules diffusing through the artificial membrane toward their activation site(s). Figure 7b illustrates quantitatively the behavior of the channels during such an experiment. Channel-open probability was largely decreased when the free [Ca2+] was reduced on the cytoplasmic (trans) side, and DTT had no effect from the cis side even if used for up to 20 min. On the other hand, SIN-1 was able to increase steady-state NPo values after a delay of 3 min. Note that gaps in NPo measurements correspond to stirring periods and delays due to current/voltage measurements under the various conditions. Following this protocol, the channels preserved their functional Ca2+-activation sites, since they recovered their activity upon restoration of the free [Ca2+] to 10 µM in the trans chamber (data not illustrated).
|
PAPA NONOate, an NO· Donor, Activates KCa Channels in the Presence of EDTA and/or K-urate
To ascertain further that NO· but not ONOO
activates
KCa channels, two sets of experiments were performed.
First, the effects of PAPA NONOate were tested at low
(0.1 µM) free [Ca2+] in the presence of EDTA, which was
added to chelate traces of heavy metals, mainly Cu2+ and
Fe2+, that might induce oxidation of reactive species.
Figure 8a shows that under control conditions, the
channel Po was very low (< 0.01). Sequential additions of
PAPA NONOate induced a concentration-dependent activation of the single channel without affecting the unit
current amplitude or the unitary conductance (Figures 8c
and 8d). Figure 8e shows the quantitative analysis of the
effects of PAPA NONOate on multiple-channel recordings in the absence and in the presence of K-urate. K-urate
was used to prevent the formation of ONOO
, a highly reactive species. The large activation of the channels observed in the presence of 100-200 µM PAPA NONOate
was related to the low NPo value in the control (low free
[Ca2+]) condition. Note that similar activations were observed in the presence of 8 µM K-urate and identical
PAPA NONOate concentrations. In two experiments, we
also verified that the activations induced by 100 µM
PAPA NONOate were not reversed by 2 mM DTT. Nevertheless KCa channels were fully reactivated upon addition of 10 µM free Ca2+ in the trans chamber, as observed
with SIN-1 (see the previous section).
|
Altogether, these results suggest that NO· generated by the degradation of PAPA NONOate in the absence of heavy metals and/or in the presence of K-urate can activate the reconstituted KCa channels.
NO· Had No Effect on ASM Cl
Channel Activity
To rule out the possibility that the effect of NO· generated
by SIN-1 was due to nonspecific action or indirect action
on the channel proteins, we tested the effect of NO· on the
behavior of Cl
channels, which have been shown to be
present with KCa channels in the same membrane preparations (36). Using PLB of identical composition to those
previously used to record KCa-channel activities, and a
symmetrical CsCl buffer system
Cs+ being a poorly permeant cation through KCa channels (36)
we measured
the activity of the unitary Cl
channel as an internal control
to test NO· specificity. Figure 9a shows that cumulative
additions of SIN-1 in the cis chamber (up to 250 µM) did
not affect the amplitude or the gating behavior of ASM
Cl
channels under steady-state conditions, consisting of
constant voltage (
40 mV), pH, and free [Ca2+]. In another set of experiments, three concentrations of SIN-1 were used at various holding potentials. Figure 9b shows
that regardless of the applied voltage, the addition of cumulative doses of SIN-1 (NO·) did not modify the open
probability (Po) of this anion-selective channel. Similarly,
addition of PAPA NONOate (up to 200 µM) had no effect on the gating of Cl
channels. Moreover DTT (up to
1 mM) had no effect on the conducting or gating behavior
of the Cl
channel (data not illustrated), thus confirming
that Cl
channels from the ASM membrane are insensitive to DTT, to NO·, and to byproducts of SIN-1. In contrast, KCa channels are rather sensitive to the direct action
of oxidizing (H2O2) and reducing agents (37).
|
Charybdotoxin Decreased the Sensitivity of BSM to SIN-1
Three kinds of potassium channels were reported to be responsible for conducting K+ ions across ASM sarcolemmal membranes: delayed rectifying; ATP-sensitive; and large conducting, Ca2+-activated K+ channels (1, 2). To prove that these last channels were involved in the control of ASM tone, additional pharmacomechanical experiments were performed on BSM in the absence or in the presence of charybdotoxin (ChTX), a rather specific KCa-channel inhibitor (38), while inhibiting guanylate cyclase activity with MB (38). As shown in Figure 10a, addition of 100 nM ChTX 10 min before challenging the tissues diminished the tension elicited by carbachol and reduced the amplitude of the relaxation caused by 100 µM SIN-1, suggesting that the ChTX-sensitive pathway (i.e., KCa channel) mediates part of the effect of NO·. To assess the specificity of the effect, tension measurements were made at different doses of SIN-1. In the presence of 10 µM MB and 100 nM ChTX, the dose-response curve was displaced toward higher concentrations of SIN-1, suggesting that blockage of KCa channels by ChTX modified the muscle fibers' sensitivity to NO·. The estimated EC50 value for SIN-1 was increased from 70 to 130 µM in the presence of ChTX (Figure 10b), thus indicating that the KCa channels of BSM contribute significantly to NO-induced relaxation even in the presence of MB. A possible contribution of KATP channels to NO-mediated relaxation, as recently reported by Murphy and Brayden (41) for mesenteric arteries, was ruled out, since 1 µM glibenclamide, a KATP inhibitor, had no effect on SIN-1-induced BSM relaxation (data not shown).
|
| |
Discussion |
|---|
|
|
|---|
In the present study, we provide direct evidence that NO·, rather than the oxidizing peroxynitrite, modifies the gating behavior of KCa channels derived from ASM, and that this effect is prevented by reducing and alkylating agents. We also investigated the role of KCa channels in NO-mediated relaxation of ASM, in an attempt to provide some insight into the mechanisms implicated in this process, using PAPA NONOate or SIN-1 in the presence of SOD as sources of NO· (25).
Previous studies have suggested that different pathways may mediate the effect of endogenous NO· on vascular and nonvascular smooth-muscle tone (5, 6, 8, 9). The different hypotheses put forward are summarized in Figure 11; a cGMP-dependent phosphorylation of contractile elements and other regulatory proteins (P1), a cGMP-dependent phosphorylation of cell-surface ion channels (P2), and a direct activation of KCa channels by NO· (P3) appear to play a role in NO-induced relaxation. There is growing evidence that the effect of NO· on ASM tone parallels an increase in cGMP level (7, 11). The first two pathways (P1 and P2) involve the activation of soluble guanylate cyclase by NO· or its derivatives (39), causing an increase in the production of cGMP. This transient increase in cGMP would activate the cGMP-dependent protein kinase known to phosphorylate (P1) regulatory proteins of contractile elements (14), and/or (P2) would activate KCa channels (16, 22, 42). The third proposed pathway involves a direct chemical interaction of NO· or its highly reactive derivative peroxynitrite with the KCa-channel protein, which would bypass the activation of soluble guanylate cyclase. The resulting effect would be an increase in K+ permeability, a hyperpolarization, and a subsequent relaxation of the tissue, as demonstrated by Bolotina and colleagues (19) in VSM. Alternatively, direct chemical modification of the channel protein by peroxynitrite oxidation or nitrothiosylation, followed by oxidation of vicinal thiols, has received little attention.
|
It has been reported previously that ASM uses cGMP-dependent routes (17) that usually result in relaxation (20,
21). We now show the existence of a cGMP-independent
pathway that mediates the effect of NO. Additionally, inhibition of the cGMP-dependent pathways P1 and P2 with
the guanylate cyclase inhibitor MB (38) partly reduced the
tissue sensitivity to NO·, as shown in Figure 10. The implication of KCa channels in the cGMP-independent pathway (P3) was demonstrated with the known specific KCa-channel inhibitors iberiotoxin (IbTX) and ChTX (11, 40). Addition of ChTX and MB before BSM were contracted with
carbachol substantially reduced the tissue sensitivity to
SIN-1, indicating that NO· or ONOO
might activate the
KCa channels. This observation correlates well with previously reported findings that IbTX, ChTX, and tetraethylammonium (TEA) (all KCa-channel blockers) consistently
decreased the sensitivity to S-nitroso-N-penicilliamine
(SNAP) (another NO· donor) in left pulmonary artery as
well as in trachea (11). A direct effect of NO· on the KCa
channel is shown in our reconstitution experiments (Figures
3b, 4, and 8), in which NO· induced an increase in Po, mainly by enhancing the number of channel openings.
These results provide further evidence of the ways by which
NO· mediates relaxation of precontracted smooth muscles, as reported by Bialecki and Fisher (11). Possible implication of K+ATP channels, as reported in the rabbit mesenteric vein by Murphy and Brayden (41), was ruled out,
since glibenclamide had no effect on NO-mediated relaxation of BSM.
To assess the direct effect of NO· on the activity of reconstituted KCa channels of ASM, bovine tracheal sarcolemma-enriched vesicles were fused into PLBs. The main
advantages of this technique are its resolution and the fact
that it allows easy control and manipulation of the experimental conditions on either side of the bilayer. Hence, this
is one of the few systems in which one can directly study
the effects of reactive species on single-channel proteins.
We have previously used this technique to describe the biophysical and biochemical properties of KCa channels (22, 33); with an average conductance of 250 pS in 250 mM KCl
cis/50 mM KCl trans, the channels show voltage-dependent open probability (22) and are sensitive to changes in
free [Ca2+] in the trans chamber, which corresponds to the
cytoplasmic side of the channels (Figures 2a and 2b). In the
experiments of interest in this regard, the channel activity
was first reduced by decreasing the cytoplasmic Ca2+ concentration from 10 µM to levels below 0.5 µM, using EGTA
and/or EDTA to chelate Ca2+ and traces of heavy metals.
Following this, cumulative doses of SIN-1 produced a concentration-dependent activation of the channels without
affecting their conductance, suggesting that in the presence
of SOD and a heavy-metal chelator, NO·
more likely than
ONOO
may react with specific sulfhydryl groups that
would be involved in modulation of the gating behavior of
KCa channels. To this effect, a time-distribution analysis of
KCa-channel kinetics revealed that NO· donors increased
overall Po by decreasing mean closed-time intervals, but
had little effect on the duration of open-channel events. In
contrast, DTT exerted a predominant lengthening effect on the channel's open-time intervals, leaving the closed-time distribution unaffected. Considering these observations,
we suggest that NO·, generated either by PAPA NONOate
or by SIN-1 + SOD, acts more potently on the KCa channel when the latter is in a closed state, whereas DTT is effective when interacting with the channel in its open conformation. At this point we have to stress that the activating
effect of NO· on the Po for the KCa channel was consistently prevented but never reversed by reducing agents such as DTT or GSH. Instead, both DTT and GSH, as well
as NEM, an alkylating agent, had stimulating effects on channel Po (Figures 6 and 7 and Table 1). In contrast, NEM
was reported to inactivate KCa channels in VSM (19). This
discrepancy between the effects induced by NEM in aortic
and airway smooth muscles will have to be assessed under
identical experimental conditions and related to the relative position of specific sulfhydryl groups.
The various NO-related species produced by NO· synthase, NO-generating drugs, or NO· donors, as well as their
main biologic targets and reactants, have been clearly
identified by Stamler and colleagues (43; Table 1). NO· can
react with thiols, metals, and oxygen, and ONOO
only
with thiols. NO· can induce nitrosylation only in the presence of an electron acceptor, and this reaction is therefore
highly dependent on the experimental conditions and the
redox state of the environment (43).
An alternative mechanism to explain the activation by SIN-1 of KCa channels would be through peroxynitrite production, would the peroxynitrite in turn oxidize or nitrate a single or multiple critical residues. However, oxidation of the KCa channel has been shown to reduce channel Po (37, 44). Furthermore, our results in the PAPA NONOate experiments (Figure 8) argue against a peroxynitrite effect. Thus, S-nitrosylation of specific cysteine residue(s) by NO· (or nitrosonium [NO+]) remains a plausible mechanism for KCa-channel activation.
Taking into account the number (i.e., 29) of cysteine
residues in the proposed sequence of the
subunit of the
bovine ASM KCa channel, which is related to the "slowpoke" family of K+ channels (45, 46), it is perplexing to
pinpoint a specific residue that could be susceptible to activation by NO·. However, an interaction with either cysteine 277 or with methionines 282 or 285, which are localized in the P loop of the pore-forming structure of the
bovine KCa channel (47), is unlikely, since neither PAPA
NONOate nor SIN-1 affected the channel's unitary conductance. The results of the reconstitution experiments in our study (Figures 6-8) strongly suggest that the site of
NO· activation would be on the cytosolic side of the
subunit, which is known to contain numerous cysteine residues (up to 16) in its internal loops (45), most of them in
the C-terminal region (47). Furthermore, 5 mM DTT, 5 mM
GSH, and 5 mM NEM on the trans side of the experimental chamber
all of which prevented activation by SIN-1 as
well as by PAPA NONOate (NO·)
did not affect the
Ca2+ sensitivity of the K+ channels, as shown in Figure 7b
and Table 1, suggesting that the Ca2+ activation sites are
independent as well as different from the sites of NO· activation. It is also unlikely that NO· interacted with the
subunit of KCa-channel protein complex, since this subunit
displays a hairpin shape, with only three cysteine residues on its single extracellular loop (48). Moreover, these residues are not flanked by the consensus sequences (K, R, D,
E) C (D, E) identified by Stamler and colleagues for various proteins known to be subjected to S-nitrosylation, such
as hemoglobin, cyclooxygenase, and guanylate cyclase (43).
Given these sequential requirements, a closer look at
the
-subunit amino-acid sequence suggests possible interference by cysteine nitrothiosylation. C975, which is a conserved residue in bovine and drosophila KCa channel (47),
is flanked by residues that might be compatible with the
mechanisms proposed herein (43). Site-specific alterations
of the channel would be the only way to confirm whether
this particular residue is involved in activation of the KCa
channel by NO·.
It should be noted that peroxynitrite formation was systematically minimized under our experimental conditions.
For instance, activation with PAPA NONOate was obtained in the presence of EDTA, a heavy metal chelator,
as well as in the presence of K-urate, which is known to scavenge ONOO
. Moreover, SOD and EGTA were present
in all experiments involving SIN-1 activation of KCa channels. On the other hand, while assessing the effects of modifying the channel redox state on modulation of the expressed
human brain KCa channel (hslo), DiChiara and Reinhart
(37) demonstrated that DTT in the same concentration range as that used in the present work increased KCa-channel open probability, which basically corroborates the results reported and discussed previously (Figures 6 and 7
and Table 1) pertaining to KCa channels from ASM. Recenlty, DTT and
-mercaptoethanol were also shown to activate maxi-K channels from equine tracheal smooth muscle
cells (4). In contrast, it was recently shown that hydrogen
peroxide (H2O2), as well as diamide, decreased the open
probability of KCa channels by an oxidative mechanism
(37, 49).
The physiologic relevance of the pathways investigated in the present study is unknown, but its independence of cGMP may underlie the need for a rapid cellular response to changes in the redox state of the environment or to very labile molecules such as NO· (12), whereas a covalent modification could result in a long-lasting effect, as reported for NANC inhibition of ASM tissue (7). Under physiopathologic conditions, the steady-state activation of KCa channels would lead to ASM repolarization or hyperpolarization, thus inhibiting Ca2+ entry via L-type, voltage-gated Ca2+-selective channels, a step that would facilitate ASM relaxation and would explain the observed BSM relaxation induced by NO· donors (44).
In conclusion, the endogenous release of NO· from nerve terminals via a NANC system, and/or from epithelial cells, as well as the exogenous application of NO donors, appear to activate several molecular mechanisms that synergetically induce ASM relaxation. Although caution must be taken not to extrapolate to in vivo situations, the results obtained with reconstituted proteins in artificial membranes, the present results strongly support our working hypothesis that NO·, but not peroxynitrite, may directly activate KCa channels. This hypothesis was further supported by the increased channel-open probability that was achieved under experimental conditions limiting peroxynitrite formation. Moreover, pharmacologic tension measurements suggest that the KCa channel is one of the effectors of the relaxant action of NO· on ASM strips. Hence, the modulation of ion-channel proteins by cellular redox potential has emerged as a significant determinant of channel function (37). Alternatively, we have shown that the NO· activation of KCa channels, which is prevented by DTT, is highly dependent on the redox state of the system, as already proposed for other ionotropic systems such as the N-methyl-D-aspartate (NMDA) receptor (49). Nevertheless, the precise chemical modification(s) of the channel proteins induced by nitrogen monoxide (NO), nitric oxide (NO·), or less likely by derivatives of NO· such as peroxynitrite, remain to be formally demonstrated.
| |
Footnotes |
|---|
Address correspondence to: Dr. Eric Rousseau, Department of Physiology and Biophysics, University of Sherbrooke, Sherbrooke, QC, J1H 5N4 Canada. E-mail: erouss01{at}courrier.usherb.ca
(Received in original form April 17, 1997 and in revised form January 21, 1998).
Note added in proof:Acknowledgments: The authors thank Drs. F. Yang, E. Troncy, and G. Blaise for their helpful collaboration in chemiluminescence measurements of NO, as well as Dr. M. Picher for discussing and revising the manuscript. This work was supported by grant MT 12287 from the Medical Research Council of Canada, and by the Association Pulmonaire du Québec. Dr. Rousseau is a senior scholar of the FRSQ. Both of the laboratories that participated in this study are members of the Health Respiratory Network of the Fonds de la Recherche en Santé du Québec (Asthma section).
Abbreviations
ASM, airway smooth muscle;
BSM, bronchial smooth muscle;
KCa, Ca2+-activated potassium channel;
PKG, cGMP-dependent protein
kinase;
ChTX, charybdotoxin;
DTT, dithiothreitol;
EC, epithelial cell;
EDHF, epithelial-derived hyperpolarizing factor;
GSH, glutathione;
IbTX, iberiotoxin;
MB, methylene blue;
NEM, N-ethylmaleimide;
SIN-1, 3-morpholinosydnonimine hydrochloride;
NO·, nitric oxide;
NO+, nitrosonium;
NANC, nonadrenergic noncholinergic;
PAPA NONOate, 1-propanamine-3-(2-hydroxy-2-nitroso-1-propylhydrazine;
Po, open probability;
ONOO
, peroxynitrite;
PLB, planar lipid bilayer;
SNAP, S-nitroso-N-acetylpenicillamine;
SM, smooth muscle;
TEA, triethylammonium;
VSM, vascular
smooth muscle.
| |
References |
|---|
|
|
|---|
1. Tomita, T., and H. Kume. 1994. Electrophysiology of potassium channels in airways smooth muscle. In Airways Smooth Muscle: Development and Regulation of Contractility. D. Raeburn and M. A. Giembycz, editors. Birkhäuser Verlag, Basel, Switzerland. 163-184.
2. Kotlikoff, M. I.. 1993. Potassium channels in airway smooth muscle: a tale of two channels. Pharmacol. Ther. 58: 1-12 [Medline].
3. Jones, T. R., L. Charette, M. L. Garcia, and G. J. Kaczorowski. 1990. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca2+-activated K+ channel inhibitor. J. Pharmacol. Exp. Ther. 256: 697-706 .
4.
Kume, H.,
I. P. Hall,
R. J. Washabau,
K. Takagi, and
M. I. Kotlikoff.
1994.
-adrenergic agonists regulate KCa channels in airway smooth muscle by
cAMP-dependent and -independent mechanisms.
J. Clin. Invest
93:
371-379
.
5.
Ignarro, L. J.,
R. E. Byrns,
G. M. Buga, and
K. S. Wood.
1987.
Endothelium-derived relaxing factor from pulmonary artery and vein possesses
pharmacologic and chemical properties identical to those of the nitric oxide radical.
Circ. Res
61:
866-879
6. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526 [Medline].
7. Ward, J. K., P. J. Barnes, S. Tadjkarimi, M. H. Yacoub, and H. G. Belvisi. 1995. Evidence for the involvement of cGMP in neural bronchodilator responses in human trachea. J. Physiol. 483: 525-536 [Medline].
8.
Ellis, J. L., and
N. D. Conanan.
1994.
Effects of potassium channel blockers
on relaxations to a nitric oxide donor and to nonadrenergic nerve stimulation in guinea pig trachea.
J. Pharmacol. Exp. Ther.
271:
782-786
9. Adnot, S., B. Raffestin, and S. Eddahibi. 1995. NO· in the lung. Respir. Physiol. 101: 109-120 [Medline].
10. Belvisi, M. G., J. K. Ward, J. A. Mitchell, and P. J. Barnes. 1995. Nitric oxide as a neurotransmitter in human airways. Arch. Int. Pharmacodyn. 329: 97-110 .
11.
Bialecki, R. A., and
C. S. Fisher.
1995.
KCa channel antagonists reduce NO·
donor-mediated relaxation of vascular and tracheal smooth muscle.
Am. J. Physiol.
268:
L152-L159
12. Moncada, S., and E. A. Higgs. 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest 21: 361-374 [Medline].
13. Högman, M., C. G. Frostell, H. Hedenström, and G. P. M. Hedenstierna. 1993. Inhalation of nitric oxide modulates adult human bronchial tone. Am. Rev. Respir. Dis 148: 1474-1478 [Medline].
14. Murad, F.. 1986. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78: 1-5 .
15.
Hamaguchi, M.,
T. Ishibashi, and
S. Imai.
1992.
Involvement of charybdotoxin-sensitive K+ channel in relaxation of bovine tracheal smooth muscle
by glyceryl trinitrate and sodium nitroprusside.
J. Pharmacol. Exp. Ther
262:
263-270
16.
Archer, S. L.,
J. M. C. Huang,
V. Hampl,
D. P. Nelson,
P. J. Shultz, and
E. K. Weir.
1994.
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K+ channel by cGMP-dependent protein
kinase.
Proc. Natl. Acad. Sci. USA
91:
7583-7587
17.
Roberston, B. E.,
R. Schubert,
J. Hescheler, and
M. T. Nelson.
1993.
cGMP-dependent protein kinase activates Ca2+-activated K+ channels in cerebral
artery smooth muscle cells.
Am. J. Physiol.
265:
C299-C303
18. Tanaguchi, J., K. I. Furukawa, and M. Shigekawa. 1993. Maxi K+ channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflügers Arch. 423: 167-172 [Medline].
19. Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen. 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853 [Medline].
20.
Zhou, H. L., and
T. J. Torphy.
1991.
Relationship between cyclic guanosine
monophosphate accumulation and relaxation of canine trachealis by nitro
vasodilators.
J. Pharmacol. Exp. Ther.
258:
972-978
21.
Jones, K. A.,
R. R. Lorenz,
D. D. Warner,
Z. S. Katusic, and
G. C. Sick.
1994.
Changes in cytosolic cGMP and calcium in airway smooth muscle relaxed by 3-morpholinosydnoninium.
Am. J. Physiol.
266:
L9-L16
22.
Alioua, A.,
J. P. Huggins, and
E. Rousseau.
1995.
PKG-I
phosphorylates
the
-subunit and upregulates reconstituted GKCa channels from tracheal
smooth muscle.
Am. J. Physiol.
268:
L1057-L1063
23.
Garcia-Calvo, M.,
H. G. Knaus,
O. McManus,
K. M. Giangiacomo,
G. J. Kaczorowski, and
M. L. Garcia.
1994.
Purification and reconstitution of
high-conductance, calcium-activated potassium channel from tracheal
smooth muscle.
J. Biol. Chem
269:
676-682
24.
Knaus, H. G.,
A. Eberhart,
R. O. A. Koch,
P. Munujos,
W. A. Schamalhofer,
J. W. Warmke,
G. J. Kaczorowski, and
M. L. Garcia.
1995.
Characterization of tissue-expressed
subunits of the high conductance Ca2+-
activated K+ channel.
J. Biol. Chem
270:
22434-22439
25. Feelisch, M., and E. A. Noack. 1987. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol. 139: 19-30 [Medline].
26. Gryglewski, R. J., R. M. J. Palmer, and S. Moncada. 1990. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454-456 .
27. Hu, P., H. Ischiropoulos, J. S. Beckman, and S. Matalon. 1994. Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10):L628-L634.
28. Haddad, I. Y., S. Zhu, J. Crow, E. Barefield, T. Gadilhe, and S. Matalon. 1996. Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14):L898-L906.
29.
Yang, F.,
E. Troncy,
M. Francoeur,
B. Vinet,
P. Vinay,
G. Czaika, and
G. Blaise.
1997.
Effects of reducing reagents and temperature on conversion
of nitrite and nitrate to nitric oxide and detection of NO· by chemiluminescence.
Clin. Chem.
43:
657-662